American Diabetes Association acknowledges Breath Well-being diabetes reversal programme

BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes

The Breathe Well-being Diabetes Management Program (BDMP), the personalised digital therapeutics program that assists individuals to manage and reverse Type 2 diabetes, has been verified by American Diabetes Association (ADA).

The objective of the clinical study by Breathe Well-being was to assess the use of BDMP application in Type 2 diabetics in achieving healthy outcomes among the Indian population.

The total group of 181 participants were divided into 3 controlled groups, the first group of 60 patients treated with the BDMP plus doctor-prescribed medication, the second group of 61 patients treated with the BDMP plus doctor-prescribed medication plus stress reduction module and a third group of 60 patients were only treated by doctor-prescribed medication.

BDMP, the holistic program based on diet, exercise and stress reduction includes intensive 1 on 1 coaching with a Breathe certified health coach, a community for peer to peer support and an interactive game design to keep individuals motivated on their journey of diabetes reversal.

At the end of the 16 weeks, patients from Cohort 1 showed an 81.6% program completion rate, an average of 5.64% of baseline body weight loss, an average of 0.68% reduction in A1C and Penn State Worry Questionnaire (PSWQ) score average change from 56.3 to 44.5 (score ranges 16-80, higher score indicates higher worry).

Patients from Cohort 2 showed an 88.5% program completion rate, an average of 6.02% of baseline body weight loss, an average of 0.74% reduction in A1C and a PSWQ score average change from 58.6 to 40.8.

Patients from Cohort 3 showed an average of 0.38% of baseline body weight loss, an average of 0.28% reduction in A1C and a PSWQ score average change from 56.2 to 55.5. The difference between all the groups was found to be statistically significant (p<0.05).

The Digital lifestyle intervention program based on diet, exercise, and stress reduction (Cohort 2) showed statistically significant results compared to the one with only diet and exercise (Cohort 1) with 95% confidence levels (p<0.05).

Rohan Verma, Co-founder & CEO, Breathe Well-being, “At Breathe Well-being, we focus on diabetes reversal and healthy living. We submitted our study to ADA on the use of Digital therapeutics that act as a valuable tool enabling personalized care among diabetics. Our lifestyle intervention program has helped patients show significant body weight loss, A1c reduction and improved stress levels. With more than 95% of patients showing HbA1c level reduction of more than 10% and 90% plus patients completely stopped or reduced medications. We are beyond delighted that ADA has acknowledged the ability of digital therapeutics to address the complex problem of diabetes. Breathe Well-being is taking its promise of a diabetes-free life a notch higher with our “No Outcome, No Pay” policy where diabetic patients end up paying only if they see a significant reduction in the HbA1c levels else the fees is refunded.”